Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlæge Marianne Hørmand ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   4.1% 1.5% 1.0% 0.8% 0.9% 0.8% 7.4% 7.4%   Credit score (0-100)   51 78 86 91 90 89 33 33   Credit rating   BBB A A AA A A BB BB   Credit limit (kDKK)   0.0 10.4 253.9 275.7 184.5 264.8 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,873 4,584 6,638 6,296 6,905 8,337 0.0 0.0   EBITDA   -33.8 1,508 2,071 1,426 937 1,188 0.0 0.0   EBIT   -325 1,228 1,847 1,059 529 808 0.0 0.0   Pre-tax profit (PTP)   -397.7 1,194.9 1,850.1 1,049.0 518.3 806.5 0.0 0.0   Net earnings   -312.9 929.3 1,431.5 812.3 400.1 629.1 0.0 0.0   Pre-tax profit without non-rec. items   -398 1,195 1,850 1,049 518 807 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   260 293 371 1,291 987 707 0.0 0.0   Shareholders equity total   -408 522 1,673 1,386 786 1,015 289 289   Interest-bearing liabilities   1,254 176 0.0 350 195 22.6 333 333   Balance sheet total (assets)   1,730 1,915 3,376 2,801 2,091 2,219 621 621   Net Debt   1,251 -3.7 -1,416 9.4 193 -493 333 333     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,873 4,584 6,638 6,296 6,905 8,337 0.0 0.0   Gross profit growth   9.9% 59.5% 44.8% -5.2% 9.7% 20.7% -100.0% 0.0%   Employees   6 6 7 7 8 9 0 0   Employee growth %   20.0% 0.0% 16.7% 0.0% 14.3% 12.5% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,730 1,915 3,376 2,801 2,091 2,219 621 621   Balance sheet change%   0.3% 10.7% 76.3% -17.0% -25.3% 6.1% -72.0% 0.0%   Added value   -33.8 1,508.2 2,071.3 1,426.5 895.9 1,188.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -583 -189 -246 453 -811 -759 -707 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -2.0 1.0 2.0 3.0 4.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -11.3% 26.8% 27.8% 16.8% 7.7% 9.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -16.1% 61.5% 70.4% 34.5% 21.8% 37.7% 0.0% 0.0%   ROI %   -34.9% 110.8% 136.1% 56.7% 34.8% 70.0% 0.0% 0.0%   ROE %   -16.4% 82.5% 130.4% 53.1% 36.9% 69.9% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   -19.1% 27.4% 49.7% 49.6% 37.7% 45.9% 46.5% 46.5%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -3,695.5% -0.2% -68.4% 0.7% 20.6% -41.5% 0.0% 0.0%   Gearing %   -307.6% 33.8% 0.0% 25.2% 24.8% 2.2% 115.2% 115.2%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   8.4% 7.3% 13.5% 10.2% 5.4% 4.6% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   0.2 0.4 1.3 0.5 0.3 0.9 0.0 0.0   Current Ratio   0.2 0.5 1.3 0.5 0.3 1.0 0.0 0.0   Cash and cash equivalent   3.1 179.9 1,416.3 340.4 2.0 515.1 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -1,583.5 -660.6 493.5 -605.5 -684.5 -34.7 -166.3 -166.3   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -6 251 296 204 112 132 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -6 251 296 204 117 132 0 0   EBIT / employee   -54 205 264 151 66 90 0 0   Net earnings / employee   -52 155 205 116 50 70 0 0